BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • Inflammatory Bowel Disease (IBD): Variety of Banked Biofluid and Tissue Samples & Customized Biosamples Collections for Further Research

Inflammatory Bowel Disease (IBD): Variety of Banked Biofluid and Tissue Samples & Customized Biosamples Collections for Further Research

Inflammatory Bowel Disease (IBD): Variety of Banked Biofluid and Tissue Samples & Customized Biosamples Collections for Further Research

04.09.2024
Inflammatory Bowel Disease (IBD): Blood, FFPE Blocks, Fresh Frozen Tissue Samples for Research | BIOMEDICA CRO
admin2024-09-04T13:35:05+00:00

A promising approach to reducing inflammation in IBD patients – the latest scientific article review by the BIOMEDICA CRO team 🧬

In a recent study, scientists from Finland and Sweden explored the anti-inflammatory, anti-proteolytic, antimicrobial, and prebiotic properties of fermented lingonberry juice, highlighting its potential benefits in alleviating Inflammatory Bowel Disease (IBD).
The study found that by targeting both the mouth and gut, fermented lingonberry juice leverages potent bioactive compounds to combat microbial dysbiosis and protect against inflammation, presenting a promising natural solution for managing Ulcerative Colitis and Crohn’s Disease.

The researchers call for further studies and human clinical trials to confirm the beneficial effects of lingonberry in reducing gastrointestinal inflammation and alleviating IBD symptoms.

For more details, please refer to the Nutrients journal article, “Oral Anti-Inflammatory and Symbiotic Effects of Fermented Lingonberry Juice – Potential Benefits in IBD.”

Order FFPE blocks, fresh frozen tissue or biofluid samples at BIOMEDICA CRO for Inflammatory Bowel Disease (IBD) research projects 🩸

At BIOMEDICA CRO, we do biosample procurement through a vast network of partnered hospitals across Ukraine, supplying high-quality biospecimens globally. Since 2017, we have provided both prospective and retrospective collections of various human biospecimen types and associated clinical data.

Our extensive network includes over 50 direct contracts with hospitals, enabling us to support research in numerous disease areas, including Inflammatory Bowel Disease (IBD). For instance, we can supply the following biospecimens from subjects with Ulcerative Colitis and Crohn’s Disease:

  • FFPE blocks with inflamed and uninflamed tissue specimens;
  • Inflamed and uninflamed fresh frozen tissue specimens;
  • Whole blood, plasma, buffy coat, serum, PBMC;
  • Saliva;
  • Urine;
  • Stool, and more.

We can also provide matched cases from a single donor, combining tissue specimens (FFPE blocks and/or fresh frozen tissue) with biofluids such as plasma, buffy coat, and serum.

By managing the collection process ourselves, we ensure seamless communication and high-quality biospecimens. Our team maintains constant contact with clinical sites and primary investigators to provide real-time updates and feedback on collections. This direct interaction guarantees that physicians fully understand the collection requirements, resulting in high-quality samples.

 

If you require a reliable partner to source biofluid or tissue specimens for your IBD research projects, BIOMEDICA CRO is ready to assist!

 

🌐 Click here to explore our extensive range of banked biological samples.

📩 Please email us to start our collaboration and order biosamples at office@biomedica-cro.com.

🚀 Follow us on LinkedIn to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of human biospecimen procurement.

Feel free to place a request for human biospecimens.

Share this post

Facebook Twitter LinkedIn
All publications
An overview of 17 000+ Ready-to-Order Banked Biosamples & Associated Data from the BIOMEDICA CRO`s Inventory
Dermatological Disorders Research: BIOMEDICA CRO’s Biospecimens Supply Capacities Overview
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.